Cargando…

COVID-19 vaccine intentions in Australia

Detalles Bibliográficos
Autores principales:	Edwards, Benjamin, Biddle, Nicholas, Gray, Matthew, Sollis, Kate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612713/ https://www.ncbi.nlm.nih.gov/pubmed/34838220 http://dx.doi.org/10.1016/S1473-3099(21)00694-0

Ejemplares similares

COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population
por: Edwards, Ben, et al.
Publicado: (2021)

COVID-19 vaccine intentions in Australia
por: Pickles, Kristen, et al.
Publicado: (2021)

Intention to vaccinate against COVID-19 in Australia
por: Rhodes, Anthea, et al.
Publicado: (2021)

Willingness to vaccinate against COVID-19 in Australia
por: Dodd, Rachael H, et al.
Publicado: (2021)

Intent to Be Vaccinated against COVID-19 in Victoria, Australia
por: Heath, Katherine, et al.
Publicado: (2022)

Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong
por: Shah, Shimoni, et al.
Publicado: (2022)

Public Perceptions of COVID-19 in Australia: Perceived Risk, Knowledge, Health-Protective Behaviors, and Vaccine Intentions
por: Faasse, Kate, et al.
Publicado: (2020)

COVID-19's impact on Australia's health research workforce
por: Peeters, Anna, et al.
Publicado: (2020)

Postexposure prophylaxis during COVID-19 lockdown in Melbourne, Australia
por: Chow, Eric P F, et al.
Publicado: (2020)

COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia
por: Bradfield, Zoe, et al.
Publicado: (2021)

Association between Covid-19 Vaccination and Influenza Vaccination Rates
por: Leuchter, Richard K., et al.
Publicado: (2022)

Local genomic sequencing enhances COVID-19 surveillance in the Northern Territory of Australia
por: Meumann, Ella M., et al.
Publicado: (2022)

On the choice of Molnupiravir and Paxlovid as the only antivirals permitted for COVID-19 infection in Australia
por: Boretti, Alberto
Publicado: (2023)

Accessing first doses of mpox vaccine made available in Victoria, Australia
por: Chow, Eric P.F., et al.
Publicado: (2023)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Reply to Basseal et al.'s "Key lessons from the COVID-19 public health response in Australia"
por: Silva, Diego S.
Publicado: (2022)

Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia
por: Barnes, Kirsten, et al.
Publicado: (2022)

COVID-19 Vaccine Effectiveness
por: Shader, Richard I.
Publicado: (2021)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Impact of general social distancing measures on incidence of influenza in Australia
por: Steinfort, Daniel P, et al.
Publicado: (2020)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

Intranasal COVID-19 vaccine: a modern vaccination approach
por: Shahnoor, Syeda, et al.
Publicado: (2023)

COVID-19 vaccin et anaphylaxie()
por: Joob, B., et al.
Publicado: (2021)

Myocarditis following COVID-19 vaccination
por: Kaul, Risheek, et al.
Publicado: (2021)

COVID-19 vaccines and neglected pregnancy
por: Dashraath, Pradip, et al.
Publicado: (2020)

Helminthiasis, eosinophils, COVID-19 and vaccination
por: Markus, Miles B.
Publicado: (2022)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
por: Shaw, Robert H, et al.
Publicado: (2021)

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
por: Fendler, Annika, et al.
Publicado: (2022)

Cerebral venous thrombosis after COVID-19 vaccines: Do we know the mechanism?
por: de Gregorio, Cesare, et al.
Publicado: (2022)

COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm
por: Magee, Laura A, et al.
Publicado: (2021)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccine prioritisation for people with disabilities
por: Epstein, Sabrina, et al.
Publicado: (2021)

COVID-19 vaccine prioritisation for individuals with psychoses
por: Kumar, Sonali, et al.
Publicado: (2021)

Challenges of COVID-19 Vaccination Delivery in Pakistan
por: Tariq, Shahan, et al.
Publicado: (2021)

VITT and Second Doses of Covid-19 Vaccine
por: Lacy, Joanne, et al.
Publicado: (2021)

Unilateral lymphadenopathy associated with COVID‐19 vaccination
por: Kado, Soichiro, et al.
Publicado: (2021)

Venezuela is collapsing without COVID-19 vaccines
por: Loyo, Enrique S López, et al.
Publicado: (2021)

COVID-19 Vaccination in Immunoglobulin A Nephropathy
por: Lim, Cynthia Ciwei, et al.
Publicado: (2021)

Gene therapy avenues and COVID-19 vaccines
por: Abu Abed, Omar S.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_36j92on7el5mfp32speodj78a5